DE:C68 / Crescent Biopharma, Inc. - Net Long/Short Value

Crescent Biopharma, Inc.
DE ˙ DB ˙ US14888D2080
DE:C68 / Crescent Biopharma, Inc. - Net Long/Short Value
Denne side viser netto-lange/korte værdiansættelser for hver institutionel besiddelse, der er rapporteret via 13F- eller NPORT-ansøgninger. For at beregne netto lang/kort værdi tilføjer vi egenkapitalværdien til værdien af call-optionen og trækker put-optionsværdien fra. Fonde, der rapporterer korte lånte positioner, vil rapportere aktieværdier som negative. Lange nettopositioner vil have positive tal i kolonnen netto lange/korte, og korte nettopositioner vil have negative værdier i denne kolonne.
Ejer Egenkapitalværdi
($1000)
Opkaldsværdi
($1000)
Sæt værdi
($1000)
Netto Lang/Kort
($1000)
Soleus Capital Management, L.P.
Bvf Inc/il
Bank Of America Corp /de/
VR Adviser, LLC
Jefferies Financial Group Inc.
Fairmount Funds Management LLC
Frazier Life Sciences Management, L.P.
Driehaus Capital Management Llc
BlackRock, Inc.
Bnp Paribas Arbitrage, Sa
Deep Track Capital, LP
Wellington Management Group Llp
Barclays Plc
Morgan Stanley
Blackstone Group Inc
Royal Bank Of Canada
Commodore Capital Lp
UBS Group AG
Fmr Llc
Braidwell Lp
Perceptive Advisors Llc
Paradigm Biocapital Advisors LP
Adage Capital Partners Gp, L.l.c.
Raymond James Financial Inc
Group One Trading, L.p.
Tang Capital Management Llc
Affinity Asset Advisors, LLC
Boxer Capital Management, LLC
SBI Securities Co., Ltd.
Logos Global Management LP
Other Listings
US:CBIO 14,24 $
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista